TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026)
TherapeuticsMD's Other Non-Current Assets came in at $395,000 for Q2 2026, down 7.7% from $428,000 a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD's Other Non-Current Assets was $444,000, up 241.5% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $130,000 in FY2024 (+124.1%), $58,000 in FY2023 (-77.1%), $253,000 in FY2022 (-99.2%) and $33.55 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Assets since Q1 2025.
- Year-over-year, Other Non-Current Assets increased in six of the last eight quarters, with growth averaging 248.9%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q3 2025 (growth of 710.3%), and the weakest in Q3 2021 (a decline of 99.5%).
- Business Quant data shows TXMD's Other Non-Current Assets at $419,000 (Q1 2026), $444,000 (Q4 2025) and $470,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 395,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 395,000.00 |
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 428,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 253,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 253,000.00 |
| Jun 30, 2022 | 254,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 33.80 Mn |
| Sep 30, 2021 | 253,000.00 |
API Access
TherapeuticsMD Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();